Jorge A Carrasquillo

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi request reprint Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer
    Jorge A Carrasquillo
    Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Eur J Nucl Med Mol Imaging 40:1384-93. 2013
  2. doi request reprint Radionuclide therapy of adrenal tumors
    Jorge A Carrasquillo
    Molecular Imaging and Therapy Service, Radiology Department Memorial Sloan Kettering, USA
    J Surg Oncol 106:632-42. 2012
  3. pmc Molecular imaging of neuroendocrine tumors
    Jorge A Carrasquillo
    Nuclear Medicine Service, Radiology Department Memorial Sloan Kettering, New York, NY, USA
    Semin Oncol 37:662-79. 2010
  4. pmc (124)I-huA33 antibody PET of colorectal cancer
    Jorge A Carrasquillo
    Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Nucl Med 52:1173-80. 2011
  5. ncbi request reprint Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride
    Neeta Pandit-Taskar
    Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York
    J Nucl Med 55:268-74. 2014
  6. pmc 124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET
    Joseph A O'Donoghue
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Nucl Med 52:1878-85. 2011
  7. pmc Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer
    Karen A Autio
    Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
    Cancer 119:3186-94. 2013
  8. pmc Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness
    E Ronan Ryan
    Department of Radiology, Division of Interventional Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Suite H118, New York, NY 10065, USA
    Radiology 268:288-95. 2013
  9. pmc Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer
    Volkan Beylergil
    aDepartment of Radiology, Molecular Imaging and Therapy Service bDepartment of Medicine, Breast Cancer Medicine Service cHuman Oncology and Pathogenesis Program dDepartment of Medical Physics eRadiochemistry and Molecular Imaging Probes Core Facility, Memorial Sloan Kettering Cancer Center Departments of fRadiology gMedicine, Weill Cornell Medical College, New York, New York, USA
    Nucl Med Commun 34:1157-65. 2013
  10. doi request reprint Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial
    Chaitanya R Divgi
    Columbia University, New York, NY 10032, USA
    J Clin Oncol 31:187-94. 2013

Collaborators

Detail Information

Publications21

  1. doi request reprint Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer
    Jorge A Carrasquillo
    Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Eur J Nucl Med Mol Imaging 40:1384-93. 2013
    ..We conducted a study to better profile the pharmacokinetics, pharmacodynamics, and biodistribution of this agent...
  2. doi request reprint Radionuclide therapy of adrenal tumors
    Jorge A Carrasquillo
    Molecular Imaging and Therapy Service, Radiology Department Memorial Sloan Kettering, USA
    J Surg Oncol 106:632-42. 2012
    ..We will review the experience using radionuclide therapy for targeting PHEO/PGL and NBs...
  3. pmc Molecular imaging of neuroendocrine tumors
    Jorge A Carrasquillo
    Nuclear Medicine Service, Radiology Department Memorial Sloan Kettering, New York, NY, USA
    Semin Oncol 37:662-79. 2010
    ..Here, we review the molecular imaging approaches for NET using various radiopharmaceuticals...
  4. pmc (124)I-huA33 antibody PET of colorectal cancer
    Jorge A Carrasquillo
    Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Nucl Med 52:1173-80. 2011
    ..We also determined the biodistribution of (124)I-huA33 when a large dose of human intravenous IgG (IVIG) was administered to manipulate the Fc receptor or when (124)I-huA33 was given via hepatic arterial infusion (HAI)...
  5. ncbi request reprint Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride
    Neeta Pandit-Taskar
    Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York
    J Nucl Med 55:268-74. 2014
    ..The review is presented in 2 parts. The first will discuss the characteristics and clinical use of (223)Ra-dichloride, and the second will discuss the β emitters (89)Sr and (153)Sm-EDTMP. ..
  6. pmc 124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET
    Joseph A O'Donoghue
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Nucl Med 52:1878-85. 2011
    ..The primary aim of this analysis was to examine the quantitative features of antibody-antigen interactions in tumors and normal tissue after parenteral administration of antitumor antibodies to human patients...
  7. pmc Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer
    Karen A Autio
    Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
    Cancer 119:3186-94. 2013
    ..The toxicity and efficacy when each agent is combined at full, recommended doses, in a repetitive fashion is not well established...
  8. pmc Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness
    E Ronan Ryan
    Department of Radiology, Division of Interventional Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Suite H118, New York, NY 10065, USA
    Radiology 268:288-95. 2013
    ..To describe a split-dose technique for fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT)-guided ablation that permits both target localization and evaluation of treatment effectiveness...
  9. pmc Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer
    Volkan Beylergil
    aDepartment of Radiology, Molecular Imaging and Therapy Service bDepartment of Medicine, Breast Cancer Medicine Service cHuman Oncology and Pathogenesis Program dDepartment of Medical Physics eRadiochemistry and Molecular Imaging Probes Core Facility, Memorial Sloan Kettering Cancer Center Departments of fRadiology gMedicine, Weill Cornell Medical College, New York, New York, USA
    Nucl Med Commun 34:1157-65. 2013
    ....
  10. doi request reprint Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial
    Chaitanya R Divgi
    Columbia University, New York, NY 10032, USA
    J Clin Oncol 31:187-94. 2013
    ..A clinical study to characterize renal masses with positron emission tomography/computed tomography (PET/CT) was undertaken...
  11. doi request reprint Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUV
    Mohiuddin Hadi
    Department of Radiology, University of California, San Francisco, CA 94158, USA
    Nucl Med Biol 35:441-5. 2008
    ..Insulin is also thought to influence tumor uptake by changing uptake in other tissues. However, little attention has been paid to understanding the variability of glucose or insulin during a single PET study...
  12. ncbi request reprint FDG PET/CT detection of intussusception caused by lymphoma in a pediatric patient
    Hye Jin Kang
    From the Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY Department of Internal Medicine, Division of Hematology Oncology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea and Pediatric Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY
    Clin Nucl Med 39:97-8. 2014
    ..The intussusception was successfully managed with medical treatment. We present FDG PET/CT findings in intussusception with non-Hodgkin lymphoma as the lead point in a pediatric patient. ..
  13. ncbi request reprint Inadvertent intra-arterial injection of (123)I-MIBG in a patient with metastatic pheochromocytoma
    Christian Lohrmann
    From the Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
    Clin Nucl Med 39:217-8. 2014
    ..During the tracer injection in the left antecubital area, the patient experienced tingling and skin redness in the left forearm and hand. ..
  14. doi request reprint Pulsed high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice
    Alfia Khaibullina
    Department of Radiology, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Nucl Med 49:295-302. 2008
    ..The aim of this study was to determine if pulsed high-intensity focused ultrasound (HIFU) exposures could enhance tumor uptake of (111)In-MX-B3, a murine IgG1kappa monoclonal antibody directed against the Le(y) antigen...
  15. doi request reprint Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy
    Constantinos T Sofocleous
    Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, NY Electronic address
    Clin Colorectal Cancer 13:27-36. 2014
    ....
  16. doi request reprint Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance
    Helmut Schoellnast
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Cardiovasc Intervent Radiol 34:S182-5. 2011
    ..Therefore, before RFA, FDG PET can guide initial needle placement, but it does not serve as a monitoring tool to evaluate residual viable tissue during the procedure...
  17. ncbi request reprint 18F-FDG uptake in metaphyseal growth arrest lines: a case study
    Remy Lim
    Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Clin Nucl Med 37:993-4. 2012
    ..We describe 18F-FDG uptake in the growth arrest lines of a 7-year-old boy treated for left distal tibial osteosarcoma...
  18. doi request reprint Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma
    Yang Lu
    Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Clin Nucl Med 37:759-62. 2012
    ..We reviewed our experience in a limited number of patients who underwent both procedures...
  19. ncbi request reprint Visualization of orbital involvement of Erdheim-Chester disease on PET/CT
    Volkan Beylergil
    From the Molecular and Imaging Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center Department of Radiology, Weill Cornell Medical Center Developmental Therapeutics Unit, and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY
    Clin Nucl Med 39:660-1. 2014
    ..An open surgical biopsy of the left orbital mass revealed xanthomatous non-Langerhans histiocytic infiltrate with Touton giant cells, positive for CD68 but negative for CD1a, establishing a diagnosis of Erdheim-Chester disease. ..
  20. doi request reprint FDG PET/CT findings in a rare case of giant fibrovascular polyp of the esophagus harboring atypical lipomatous tumor/well-differentiated liposarcoma
    Volkan Beylergil
    From the Molecular and Imaging Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York Department of Radiology, Weill Cornell Medical Center, New York, NY Department of Radiology, Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ Division of Hematology Oncology, Department of Medicine, and Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY
    Clin Nucl Med 39:288-91. 2014
    ..Mouse double minute 2 homolog amplification was noted by fluorescence in situ hybridization diffusely in the giant polyp consistent with well-differentiated liposarcoma in a giant fibrovascular polyp. ..
  21. pmc Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor
    Jaspreet Singh Jaggi
    Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Clin Invest 117:2422-30. 2007
    ..The ability to reduce the serum persistence of conjugated IgG antibodies after their infusion can enhance their therapeutic index, resulting in improved therapeutic and diagnostic efficacy...